SUMMARY HLA, A, B, and DR typing was done on seven of 10 patients with lymphoma, and six patients with carcinoma, all of whom had a flat small intestinal mucosa. Sixty-nine per cent (nine of 13) had HLA B8 and 71% (five of seven) had DR3. The corresponding levels for the local coeliac population are 76% and 84% respectively and the local non-coeliac population 43% and 44%. Two of the patients with lymphoma had a child with coeliac disease. The histological type of the lymphoma was malignant histiocytosis of the intestine in seven, histiocytic lymphoma in two, and was not classifiable in one. The similarity of the HLA type suggests that the flat mucosa in both groups is due to coeliac disease.
During a 12 year period from mid 1969 to 1981 16 patients with malignant disease and a flat intestinal mucosa consistent with coeliac disease were seen in Galway, an area with a high prevalence of coeliac disease.' This provided the opportunity to HLA type most of these patients and to compare the typing with that of the local population and local coeliac patients.2 3 Whether coeliac patients who develop lymphoma and other types of malignancy are similar to coeliacs who do not develop malignancy is a matter of debate. It has been suggested that the flat mucosa of some of the patients is not due to coeliac disease but might result from a long-standing lymphoma. If the genetic background, as judged by HLA typing of the patients who develop malignancy, is similar to that of coeliacs without malignancy from the same ethnic background, this would favour the suggestion that malignancy develops as a complication of coeliac disease. Similarly, the occurrence of individuals with a flat mucosa and malignancy in families of patients with coeliac disease would favour this theory.
Recently, there has been renewed interest in the histological type of lymphoma seen in these patients and this is described in our patients.4
Received for publication 7 December 1981 Methods HLA A and B typing was done by the standard microlymphocytotoxicity test5 with sera supplied by the NIH. HLA-DR typing was done by the long B-cell enriched microlymphocytotoxicity test6 with sera supplied by Professor E D Albert (Munich).
The classification used in the histological typing of the lymfhoma was modified from Robb, Smith, and
Taylor. In this classification, the histiocytic type is subdivided into malignant histiocytosis and histiocytic lymphoma (reticulum cell sarcoma). In the former, there is widespread dissemination of malignant histiocytes often showing erythrophagocytosis or other phagocytic activity. In the latter a tumour mass is present with or without metastases.
PATIENTS
All patients had a flat jejunal mucosa and the type of malignancy was confirmed histologically at biopsy or necropsy. The initial presenting symptoms and signs are not described as they are similar to those in other series.811
Patients with lymphoma Eight had been on a gluten-free diet for two to 25 years, one for six months, and one for a few days.
Two of those on a gluten-free diet for longer than six months showed no improvement. The others 662 improved clinically with weight gain of greater than 6 kg. Three of these were on corticosteroids.
In eight patients the intestinal mucosa was studied a second time either by biopsy or at necropsy. In three who were adhering to a strict gluten-free diet there was improvement and one of five who, although on a gluten-free diet, were not adhering to it strictly also improved. 
Discussion
An indisputable diagnosis of coeliac disease requires the demonstration of abnormal small intestinal mucosa, which improves when gluten is excluded from the diet and deteriorates when gluten is reintroduced. In practice, and in particular in adults, it is unusual to require more than the demonstration of significant mucosal abnormality and its improvement on a gluten-free diet. As patients with malignancy and a flat intestinal mucosa frequently die shortly after the diagnosis of malignancy, there is often no opportunity to assess the effect of a gluten-free diet. In some patients the clinical course even with a gluten-free diet is of steady deterioration without morphological improvement in the intestinal mucosa, and malignancy, usually lymphoma, being dignosed at necropsy. In the absence of demonstrable mucosal improvement in some of these patients the diagnosis of coeliac disease could be disputed. Nevertheless, there was no evidence that other disorders associated with a flat mucosa were present. The effect of gluten exclusion from the diet could not be ascertained in some because of the short duration of history before death.
The HLA type of the coeliacs and non-coeliacs in the local population has been detailed previously.2 3 Seventy-six per cent of the local coeliacs have HLA B8 and 84% DR3. This is a similar proportion to most other coeliac populations12 13 with the exception of Southern Germany. 14 In the noncoeliac population the comparable figures are 43%
and 44%. The incidence of HLA B8 and DR3 in the non-coeliac population in the Galway area is higher than elsewhere. Nine (69%) of the 13 patients with malignancy in whom HLA typing was done had HLA B8 and five of seven had DR3. Information on HLA type in a series of patients with lymphoma or carcinoma and coeliac disease against a background of HLA type in a local population of coeliacs is not available in the literature. The similarity of the proportion of HLA B8 and DR3 in the malignant and non-malignant coeliac groups suggest that the two groups share similar genetic backgrounds and we believe that both groups are coeliacs. This opinion is supported by the presence of coeliac disease in two of the children of patients with lymphoma. Why some coeliacs develop malignancy and others do not is as obscure as the reasons why lymphoma or other malignancies develop in the general population. Abnormal absorption of environmental carcinogens or undue penetration of the abnormal jejunal mucosa by oncogenic viruses in the presence of disturbed immunity are speculative possibilities.
Although we believe that the lymphomas and at least some of the carcinomas arise in relationship to coeliac disease, we cannot exclude a primary relationship to HLA B8, although we are not aware of such an association of HLA B8 with malignancy.
In many of these patients the almost simultaneous diagnosis of coeliac disease and malignancy suggests that the latter was the event that drew attention to the underlying partially or totally asymptomatic coeliac disease.
During the period these patients were seen (1969 to 1981) 
